Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases

Clinical trial NCT01798108 · COMPLETED

Trial details

NCT number: NCT01798108
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Metastasis

Start date: 2001-08-14
Primary completion: 2003-06-25
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.